Go Pro
→ First Look: Elon’s “Starphone” (From Stansberry Research) (Ad)tc pixel Free SMIF Stock Alerts

TwentyFour Select Monthly Income Fund (SMIF) Competitors

TwentyFour Select Monthly Income Fund logo
GBX 84.40 -0.10 (-0.12%)
As of 12:42 PM Eastern
Compare

SMIF vs. IHP, GROW, FCSS, BPCR, and GSS

Should you buy TwentyFour Select Monthly Income Fund stock or one of its competitors? TwentyFour Select Monthly Income Fund's main competitors and comparable companies include IntegraFin (IHP), Molten Ventures (GROW), Fidelity China Special (FCSS), BioPharma Credit (BPCR), and Genesis Emerging Markets Fund (GSS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "asset management & custody banks" industry.

How does TwentyFour Select Monthly Income Fund compare to IntegraFin?

TwentyFour Select Monthly Income Fund (LON:SMIF) and IntegraFin (LON:IHP) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, earnings, institutional ownership, media sentiment, valuation and risk.

TwentyFour Select Monthly Income Fund has a net margin of 57.51% compared to IntegraFin's net margin of 28.60%. IntegraFin's return on equity of 27.60% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
IntegraFin 28.60%27.60%20.29%

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.4%. IntegraFin pays an annual dividend of GBX 11.30 per share and has a dividend yield of 3.1%. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. IntegraFin pays out 59.2% of its earnings in the form of a dividend.

15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. Comparatively, 44.0% of IntegraFin shares are owned by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are owned by company insiders. Comparatively, 14.5% of IntegraFin shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

TwentyFour Select Monthly Income Fund has a beta of 0.657, suggesting that its share price is 34% less volatile than the broader market. Comparatively, IntegraFin has a beta of 1.276, suggesting that its share price is 28% more volatile than the broader market.

IntegraFin has higher revenue and earnings than TwentyFour Select Monthly Income Fund. TwentyFour Select Monthly Income Fund is trading at a lower price-to-earnings ratio than IntegraFin, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.82N/A£5.7514.68
IntegraFin£165.40M7.30£52.54M£19.1019.15

IntegraFin has a consensus target price of GBX 435, indicating a potential upside of 18.95%. Given IntegraFin's stronger consensus rating and higher probable upside, analysts plainly believe IntegraFin is more favorable than TwentyFour Select Monthly Income Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TwentyFour Select Monthly Income Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
IntegraFin
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

In the previous week, IntegraFin had 7 more articles in the media than TwentyFour Select Monthly Income Fund. MarketBeat recorded 8 mentions for IntegraFin and 1 mentions for TwentyFour Select Monthly Income Fund. IntegraFin's average media sentiment score of 1.13 beat TwentyFour Select Monthly Income Fund's score of 0.75 indicating that IntegraFin is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TwentyFour Select Monthly Income Fund
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IntegraFin
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

IntegraFin beats TwentyFour Select Monthly Income Fund on 14 of the 17 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Molten Ventures?

TwentyFour Select Monthly Income Fund (LON:SMIF) and Molten Ventures (LON:GROW) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, dividends, earnings, profitability and institutional ownership.

In the previous week, TwentyFour Select Monthly Income Fund had 1 more articles in the media than Molten Ventures. MarketBeat recorded 1 mentions for TwentyFour Select Monthly Income Fund and 0 mentions for Molten Ventures. TwentyFour Select Monthly Income Fund's average media sentiment score of 0.75 beat Molten Ventures' score of 0.00 indicating that TwentyFour Select Monthly Income Fund is being referred to more favorably in the media.

Company Overall Sentiment
TwentyFour Select Monthly Income Fund Positive
Molten Ventures Neutral

Molten Ventures has a net margin of 75.09% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. Molten Ventures' return on equity of 9.21% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
Molten Ventures 75.09%9.21%-3.46%

15.1% of TwentyFour Select Monthly Income Fund shares are held by institutional investors. Comparatively, 40.5% of Molten Ventures shares are held by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are held by insiders. Comparatively, 1.6% of Molten Ventures shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

TwentyFour Select Monthly Income Fund has a beta of 0.657, meaning that its share price is 34% less volatile than the broader market. Comparatively, Molten Ventures has a beta of 1.9564402, meaning that its share price is 96% more volatile than the broader market.

Molten Ventures has a consensus price target of GBX 638.67, suggesting a potential downside of 5.94%. Given Molten Ventures' stronger consensus rating and higher probable upside, analysts plainly believe Molten Ventures is more favorable than TwentyFour Select Monthly Income Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TwentyFour Select Monthly Income Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Molten Ventures
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

TwentyFour Select Monthly Income Fund has higher earnings, but lower revenue than Molten Ventures. Molten Ventures is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.82N/A£5.7514.68
Molten Ventures£148M7.92-£33.58M£69.009.84

Summary

Molten Ventures beats TwentyFour Select Monthly Income Fund on 10 of the 15 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Fidelity China Special?

TwentyFour Select Monthly Income Fund (LON:SMIF) and Fidelity China Special (LON:FCSS) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.4%. Fidelity China Special pays an annual dividend of GBX 8 per share and has a dividend yield of 3.2%. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Fidelity China Special pays out 26.9% of its earnings in the form of a dividend.

Fidelity China Special has a net margin of 81.41% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. Fidelity China Special's return on equity of 9.12% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
Fidelity China Special 81.41%9.12%N/A

15.1% of TwentyFour Select Monthly Income Fund shares are owned by institutional investors. Comparatively, 7.8% of Fidelity China Special shares are owned by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are owned by insiders. Comparatively, 0.1% of Fidelity China Special shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Fidelity China Special has higher revenue and earnings than TwentyFour Select Monthly Income Fund. Fidelity China Special is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.82N/A£5.7514.68
Fidelity China Special£146.54M7.85£997.06M£29.758.50

TwentyFour Select Monthly Income Fund has a beta of 0.657, indicating that its stock price is 34% less volatile than the broader market. Comparatively, Fidelity China Special has a beta of 0.919, indicating that its stock price is 8% less volatile than the broader market.

In the previous week, TwentyFour Select Monthly Income Fund and TwentyFour Select Monthly Income Fund both had 1 articles in the media. Fidelity China Special's average media sentiment score of 0.86 beat TwentyFour Select Monthly Income Fund's score of 0.75 indicating that Fidelity China Special is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TwentyFour Select Monthly Income Fund
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fidelity China Special
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Fidelity China Special beats TwentyFour Select Monthly Income Fund on 7 of the 12 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to BioPharma Credit?

TwentyFour Select Monthly Income Fund (LON:SMIF) and BioPharma Credit (LON:BPCR) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, profitability, risk, analyst recommendations, media sentiment, institutional ownership, dividends and earnings.

In the previous week, BioPharma Credit had 3 more articles in the media than TwentyFour Select Monthly Income Fund. MarketBeat recorded 4 mentions for BioPharma Credit and 1 mentions for TwentyFour Select Monthly Income Fund. BioPharma Credit's average media sentiment score of 0.76 beat TwentyFour Select Monthly Income Fund's score of 0.75 indicating that BioPharma Credit is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TwentyFour Select Monthly Income Fund
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BioPharma Credit
0 Very Positive mention(s)
4 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BioPharma Credit has a net margin of 92.62% compared to TwentyFour Select Monthly Income Fund's net margin of 57.51%. BioPharma Credit's return on equity of 11.29% beat TwentyFour Select Monthly Income Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
BioPharma Credit 92.62%11.29%4.98%

15.1% of TwentyFour Select Monthly Income Fund shares are held by institutional investors. Comparatively, 31.3% of BioPharma Credit shares are held by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are held by insiders. Comparatively, 0.1% of BioPharma Credit shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

BioPharma Credit has higher revenue and earnings than TwentyFour Select Monthly Income Fund. BioPharma Credit is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.82N/A£5.7514.68
BioPharma Credit£132.06M0.08£10.42B£11.400.09

TwentyFour Select Monthly Income Fund has a beta of 0.657, meaning that its stock price is 34% less volatile than the broader market. Comparatively, BioPharma Credit has a beta of 0.22688746, meaning that its stock price is 77% less volatile than the broader market.

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.4%. BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 711.4%. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. BioPharma Credit pays out 61.4% of its earnings in the form of a dividend. BioPharma Credit is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

BioPharma Credit beats TwentyFour Select Monthly Income Fund on 10 of the 14 factors compared between the two stocks.

How does TwentyFour Select Monthly Income Fund compare to Genesis Emerging Markets Fund?

TwentyFour Select Monthly Income Fund (LON:SMIF) and Genesis Emerging Markets Fund (LON:GSS) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

In the previous week, TwentyFour Select Monthly Income Fund had 1 more articles in the media than Genesis Emerging Markets Fund. MarketBeat recorded 1 mentions for TwentyFour Select Monthly Income Fund and 0 mentions for Genesis Emerging Markets Fund. TwentyFour Select Monthly Income Fund's average media sentiment score of 0.75 beat Genesis Emerging Markets Fund's score of 0.00 indicating that TwentyFour Select Monthly Income Fund is being referred to more favorably in the media.

Company Overall Sentiment
TwentyFour Select Monthly Income Fund Positive
Genesis Emerging Markets Fund Neutral

15.1% of TwentyFour Select Monthly Income Fund shares are held by institutional investors. 0.1% of TwentyFour Select Monthly Income Fund shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Genesis Emerging Markets Fund is trading at a lower price-to-earnings ratio than TwentyFour Select Monthly Income Fund, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TwentyFour Select Monthly Income Fund£17.70M17.82N/A£5.7514.68
Genesis Emerging Markets Fund£250.40M0.00N/A£140.70N/A

TwentyFour Select Monthly Income Fund pays an annual dividend of GBX 7.05 per share and has a dividend yield of 8.4%. Genesis Emerging Markets Fund pays an annual dividend of GBX 0.17 per share. TwentyFour Select Monthly Income Fund pays out 122.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Genesis Emerging Markets Fund pays out 0.1% of its earnings in the form of a dividend.

TwentyFour Select Monthly Income Fund has a net margin of 57.51% compared to Genesis Emerging Markets Fund's net margin of 0.00%. TwentyFour Select Monthly Income Fund's return on equity of 5.95% beat Genesis Emerging Markets Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
TwentyFour Select Monthly Income Fund57.51% 5.95% N/A
Genesis Emerging Markets Fund N/A N/A N/A

Summary

TwentyFour Select Monthly Income Fund beats Genesis Emerging Markets Fund on 8 of the 11 factors compared between the two stocks.

Get TwentyFour Select Monthly Income Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMIF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMIF vs. The Competition

Export
MetricTwentyFour Select Monthly Income FundCapital Markets IndustryFinance SectorLON Exchange
Market Cap£315.53M£5.26B£13.68B£2.89B
Dividend Yield7.10%7.51%5.99%6.22%
P/E Ratio14.6829.5124.58366.61
Price / Sales17.821,260.21513.8789,510.94
Price / CashN/A47.8929.8727.89
Price / BookN/A3.502.706.33
Net IncomeN/A£417.69M£1.32B£5.89B
7 Day Performance-0.47%-1.43%0.30%-0.12%
1 Month Performance-1.52%-3.10%-2.16%5.22%
1 Year Performance-3.87%1.00%7.23%18.52%

TwentyFour Select Monthly Income Fund Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMIF
TwentyFour Select Monthly Income Fund
N/AGBX 84.40
-0.1%		N/A-3.8%£315.53M£17.70M14.68N/A
IHP
IntegraFin
4.0119 of 5 stars		GBX 371
-0.4%		GBX 435
+17.3%		+9.9%£1.23B£165.40M19.423,520
GROW
Molten Ventures
0.6572 of 5 stars		GBX 668.50
-0.4%		GBX 638.67
-4.5%		+78.8%£1.16B£148M9.6920
FCSS
Fidelity China Special
N/AGBX 248
+1.2%		N/A-21.8%£1.11B£146.54M8.34N/A
BPCR
BioPharma Credit
N/AGBX 0.97
-0.4%		N/A+9.4%£1.09B£132.06M0.09N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:SMIF) was last updated on 9/28/2026 by MarketBeat.com Staff.
From Our Partners
Management just bought 2.8 million shares
Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...
Monument Traders Alliance | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Analyst nicknamed “The Prophet” issues new warning for America
Whitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...
Stansberry Research | Sponsoredtc pixel
A “bloodbath” Is Coming
Reports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...
TradeSmith | Sponsoredtc pixel
Elon Musk’s Hushed FCC Filing. Dec 8th.
Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...
Paradigm Press | Sponsoredtc pixel
Iran War WARNING: Something Just Changed
A powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...
Banyan Hill Publishing | Sponsoredtc pixel
This AI Stock Reminds One Analyst of Early Nvidia
Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...
Brownstone Research | Sponsoredtc pixel
"How Much Can I Actually Spend Each Year With $2.5M Saved?"
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel